Page 18 - Diagnosis and treatment of interstitial cystitis/bladder pain syndrome

iC/BPS guideline

117. Gafni-Kane A, Botros SM, Du H, et al. Measuring the success of combined intravesical dimethyl sulfoxide and 141. Nordling J, van Ophoven A. Intravesical glycosaminoglycan replenishment with chondroitin sulphate
triamcinolone for treatment of bladder pain syndrome/interstitial cystitis. Int Urogynecol J 2013;24:303- in chronic forms of cystitis. A multinational, multicentre, prospective observational clinical trial.
11. http://dx.doi.org/10.1007/s00192-012-1832-x Arzneimittelforschung 2008;58:328-35.
118. Mouracade P, Saussine C. [Interstitial cystitis in 2008]. Prog Urol 2008;18:418-25. http://dx.doi. 142. Steinhoff G. The efficacy of chondroitin sulphate in treating interstitial cystitis. Eur Urol Suppl
org/10.1016/j.purol.2008.04.001 2003:14-6.
119. DR Erickson. Bladder pain syndrome: Current terminology, diagnosis, and treatment. AUA Update Series 2009;28. 143. Sorensen RB. Chondroitin sulphate in the treatment of interstitial cystitis and chronic inflammatory disease
120. Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalin- of the urinary bladder. Eur Urol 2003:16-8.
ized lidocaine in patients with interstitial cystitis. Urology 2005;65:45-8. http://dx.doi.org/10.1016/j. 144. Nickel JC, Egerdie B, Downey J, et al. A real-life multicentre clinical practice study to evaluate the
urology.2004.08.056 efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int
121. Kuo HC. Urodynamic results of intravesical heparin therapy for women with frequency urgency syndrome 2009;103:56-60. http://dx.doi.org/10.1111/j.1464-410X.2008.08028.x
and interstitial cystitis. J Formos Med Assoc 2001;100:309-14. 145. Nickel JC, Egerdie RB, Steinhoff G, et al. A multicentre, randomized, double-blind, parallel group pilot
122. Perez-Marrero R, Emerson LE, Maharajh DO, et al. Prolongation of response to DMSO by heparin mainten- evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control
ance. Urology 1993;41:64-6. http://dx.doi.org/10.1016/0090-4295(93)90198-J in patients with interstitial cystitis/painful bladder syndrome. Urology 2010;76:804-9. http://dx.doi.
123. Welk BK, Teichman JM. Dyspareunia response in patients with interstitial cystitis treated with intra- org/10.1016/j.urology.2010.03.016
vesical lidocaine, bicarbonate, and heparin. Urology 2008;71:67-70. http://dx.doi.org/10.1016/j. 146. Nickel JC, Hanno P, Kumar K, et al. Second multicentre, randomized, double-blind, parallel-group evalua-
urology.2007.09.067 tion of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle
124. Nomiya A, Naruse T, Niimi A, et al. On- and post-treatment symptom relief by repeated instillations control in subjects with interstitial cystitis/bladder pain syndrome. Urology 2012;79:1220-4. http://
of heparin and alkalized lidocaine in interstitial cystitis. Int J Urol 2013;20:1118-22. http://dx.doi. dx.doi.org/10.1016/j.urology.2012.01.059
org/10.1111/iju.12120 147. Thakkinstian A, Nickel JC. Efficacy of intravesical chondroitin sulphate in treatment of interstitial cystitis/
125. Parsons CL, Zupkas P, Proctor J, et al. Alkalinized lidocaine and heparin provide immediate relief of bladder pain syndrome (IC/BPS): Individual patient data (IPD) meta-analytical approach. Can Urol Assoc
pain and urgency in patients with interstitial cystitis. J Sex Med 2012;9:207-12. http://dx.doi. J 2013;7:195-200. http://dx.doi.org/10.5489/cuaj.1257
org/10.1111/j.1743-6109.2011.02542.x 148. Henry R, Patterson L, Avery N, et al. Absorption of alkalized intravesical lidocaine in normal and inflamed
126. Riedl CR, Engelhardt PF, Daha KL, et al. Hyaluronan treatment of interstitial cystitis/painful bladder bladders: a simple method for improving bladder anesthesia. J Urol 2001;165:1900-3. http://dx.doi.
syndrome. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:717-21. http://dx.doi.org/10.1007/ org/10.1016/S0022-5347(05)66238-6
s00192-007-0515-5 149. Henry RA, Patterson L, Nickel C, et al. Alkalinized intravesical lidocaine to treat interstitial cystitis: absorption
127. Daha LK, Riedl CR, Lazar D, et al. Do cystometric findings predict the results of intravesical hyaluronic kinetics in normal and interstitial cystitis bladders. Urology 2001;57:119. http://dx.doi.org/10.1016/
acid in women with interstitial cystitis? Eur Urol 2005;47:393-7. http://dx.doi.org/10.1016/j. S0090-4295(01)01069-X
eururo.2004.10.022 150. Nickel JC, Moldwin R, Lee S, et al. Intravesical alkalinized lidocaine (PSD597) offers sustained relief
128. Morales A, Emerson L, Nickel JC, et al. Intravesical hyaluronic acid in the treatment of refractory interstitial from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int 2009;103:910-8. http://
cystitis. J Urol 1996;156:45-8. http://dx.doi.org/10.1016/S0022-5347(01)65933-0 dx.doi.org/10.1111/j.1464-410X.2008.08162.x
129. Kallestrup EB, Jorgensen SS, Nordling J, et al. Treatment of interstitial cystitis with Cystistat: A hyaluronic acid 151. Nickel JC, Jain P, Shore N, et al. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder
product. Scand J Urol Nephrol 2005;39:143-7. http://dx.doi.org/10.1080/00365590410015876-1 pain syndrome: safety and efficacy of a new drug delivery device. Sci Transl Med 2012;4:143ra100.
130. Kim A, Lim B, Song M, et al. Pretreatment features to influence effectiveness of intravesical hyaluronic http://dx.doi.org/10.1126/scitranslmed.3003804
Acid instillation in refractory interstitial cystitis/painful bladder syndrome. Int Neurourol J 2014;18:163-7. 152. Rosamilia A, Dwyer PL, Gibson J. Electromotive drug administration of lidocaine and dexamethasone
http://dx.doi.org/10.5213/inj.2014.18.3.163 followed by cystodistension in women with interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct
131. Leppilahti M, Hellstrom P, Tammela TL. Effect of diagnostic hydrodistension and four intravesical hyal- 1997;8:142-5. http://dx.doi.org/10.1007/BF02764846
uronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical 153. Fall M, Oberpenning F, Peeker R. Treatment of bladder pain syndrome/interstitial cystitis 2008:
response in patients with interstitial cystitis. Urology 2002;60:46-51. http://dx.doi.org/10.1016/ Can we make evidence-based decisions? Eur Urol 2008;54:65-75. http://dx.doi.org/10.1016/j.
S0090-4295(02)01613-8 eururo.2008.03.086
132. Porru D, Campus G, Tudino D, et al. Results of treatment of refractory interstitial cystitis with intravesical 154. Vij M, Srikrishna S, Cardozo L. Interstitial cystitis: diagnosis and management. Eur J Obstet Gynecol Reprod
hyaluronic acid. Urol Int 1997;59:26-9. http://dx.doi.org/10.1159/000283012 Biol 2012;161:1-7. http://dx.doi.org/10.1016/j.ejogrb.2011.12.014
133. Favre G, Gonzalez M, Zubieta M, et al. Experience of endovesical hyaluronic acid in the treatment 155. Mourtzoukou EG, Iavazzo C, Falagas ME. Resiniferatoxin in the treatment of interstitial cystitis: A sys-
of interstitial cystitis/ painful bladder syndrome. International Continence Society – Annual Meeting, tematic review. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:1571-6. http://dx.doi.org/10.1007/
Barcelona, Spain, 2013, Non-Moderated Poster 666. s00192-008-0663-2
134. Sambandan N, Briggs K, Sutherland S, et al. The efficacy and safety of intravesical hyaluronic acid in 156. Mayer R, Propert KJ, Peters KM, et al. A randomized controlled trial of intravesical Bacillus Calmette-Guerin
patients with interstitial cystitis/ painful bladder syndrome: practice experience. International Continence for treatment refractory interstitial cystitis. J Urol 2005;173:1186-91. http://dx.doi.org/10.1097/01.
Society – Annual Meeting, Barcelona, Spain, 2013, Non-Moderated Poster 791. ju.0000152337.82806.e8
135. Gulpinar O, Kayis A, Suer E, et al. Clinical comparision of intravesical hyaluronic acid and hyaluronic 157. Peters K, Diokno A, Steinert B, et al. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the
acid-chondroitin sulphate therapy for patients with bladder pain syndrome/interstitital cystitis. Can Urol treatment of interstitial cystitis: A double-blind, prospective, placebo controlled trial. J Urol 1997;157:2090-
Assoc J 2014;8:E610-4. http://dx.doi.org/10.5489/cuaj.2036 4. http://dx.doi.org/10.1016/S0022-5347(01)64682-2
136. Porru D, Leva F, Parmigiani A, et al. Impact of intravesical hyaluronic acid and chondroitin sulfate on blad- 158. Bade JJ, Laseur M, Nieuwenburg A, et al. A placebo-controlled study of intravesical pentosanpolysulphate
der pain syndrome/interstitial cystitis. Int Urogynecol J 2012;23:1193-9. http://dx.doi.org/10.1007/ for the treatment of interstitial cystitis. Br J Urol 1997;79:168-71. http://dx.doi.org/10.1046/j.1464-
s00192-011-1546-5 410X.1997.03384.x
137. Cervigni M, Natale F, Nasta L, et al. Intravesical hyaluronic acid and chondroitin sulphate for bladder pain 159. Davis EL, El Khoudary SR, Talbott EO, et al. Safety and efficacy of the use of intravesical and oral pentosan
syndrome/interstitial cystitis: long-term treatment results. Int Urogynecol J 2012;23:1187-92. http:// polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 2008;179:177-85.
dx.doi.org/10.1007/s00192-012-1742-y http://dx.doi.org/10.1016/j.juro.2007.08.170
138. Chintea CL, Belal M. Is there enough evidence for the use of intravesical instillations of glycosamino- 160. Lander EB, See JR. Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier
glycan analogues in interstitial cystitis? BJU Int 2013;111:192-3. http://dx.doi.org/10.1111/j.1464- for interstitial cystitis. Am J Clin Exp Urol 2014;2:145-8.
410X.2012.11635.x 161. Barbalias GA, Liatsikos EN, Athanasopoulos A, et al. Interstitial cystitis: bladder training with intravesical
139. Chintea CL, Belal M. Is there enough evidence for the use of intravesical instillations of glycosamino- oxybutynin. J Urol 2000;163:1818-22. http://dx.doi.org/10.1016/S0022-5347(05)67551-9
glycan analogues in interstitial cystitis? BJU Int 2013;111:192-3. http://dx.doi.org/10.1111/j.1464- 162. De Wachter S, Wyndaele JJ. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J
410X.2012.11635.x Urol 2003;169:1892-5. http://dx.doi.org/10.1097/01.ju.0000049903.60057.4b
140. Chintea CL, Belal M. Is there enough evidence for the use of intravesical instillations of glycosamino- 163. Rovner E, Propert KJ, Brensinger C, et al. Treatments used in women with interstitial cystitis: the interstitial
glycan analogues in interstitial cystitis? BJU Int 2013;111:192-3. http://dx.doi.org/10.1111/j.1464- cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology
410X.2012.11635.x 2000;56:940-5. http://dx.doi.org/10.1016/S0090-4295(00)00845-1

CUAJ • May-June 2016 • Volume 10, Issues 5-6 E153